Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

421 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In-hospital mortality and organ failure after open and endovascular thoraco-abdominal aortic surgery can be predicted by increased levels of circulating dipeptidyl peptidase 3.
Gombert A, Barbati M, Kotelis D, Simon TP, Breuer T, Hartmann O, Santos K, Bergmann D, Schulte J, Marx G, Jacobs M, Stoppe C. Gombert A, et al. Among authors: hartmann o. Eur J Cardiothorac Surg. 2021 Apr 29;59(4):750-757. doi: 10.1093/ejcts/ezaa413. Eur J Cardiothorac Surg. 2021. PMID: 33236058
Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics.
Deniau B, Rehfeld L, Santos K, Dienelt A, Azibani F, Sadoune M, Kounde PR, Samuel JL, Tolpannen H, Lassus J, Harjola VP, Vodovar N, Bergmann A, Hartmann O, Mebazaa A, Blet A. Deniau B, et al. Among authors: hartmann o. Eur J Heart Fail. 2020 Feb;22(2):290-299. doi: 10.1002/ejhf.1601. Epub 2019 Aug 31. Eur J Heart Fail. 2020. PMID: 31472040 Free article.
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study.
Blet A, Deniau B, Santos K, van Lier DPT, Azibani F, Wittebole X, Chousterman BG, Gayat E, Hartmann O, Struck J, Bergmann A, Antonelli M, Beishuizen A, Constantin JM, Damoisel C, Deye N, Di Somma S, Dugernier T, François B, Gaudry S, Huberlant V, Lascarrou JB, Marx G, Mercier E, Oueslati H, Pickkers P, Sonneville R, Legrand M, Laterre PF, Mebazaa A; AdrenOSS-1 Study Investigators. Blet A, et al. Among authors: hartmann o. Crit Care. 2021 Feb 15;25(1):61. doi: 10.1186/s13054-021-03471-2. Crit Care. 2021. PMID: 33588925 Free PMC article.
High plasma dipeptidyl peptidase 3 levels are associated with mortality and organ failure in shock: results from the international, prospective and observational FROG-ICU cohort.
Deniau B, Picod A, Van Lier D, Vaittinada Ayar P, Santos K, Hartmann O, Gayat E, Mebazaa A, Blet A, Azibani F. Deniau B, et al. Among authors: hartmann o. Br J Anaesth. 2022 Feb;128(2):e54-e57. doi: 10.1016/j.bja.2021.11.021. Epub 2021 Dec 8. Br J Anaesth. 2022. PMID: 34895716 Free article. No abstract available.
Circulating dipeptidyl peptidase-3 at admission is associated with circulatory failure, acute kidney injury and death in severely ill burn patients.
Dépret F, Amzallag J, Pollina A, Fayolle-Pivot L, Coutrot M, Chaussard M, Santos K, Hartmann O, Jully M, Fratani A, Oueslati H, Cupaciu A, Benyamina M, Guillemet L, Deniau B, Mebazaa A, Gayat E, Farny B, Textoris J, Legrand M; PRONOBURN group. Dépret F, et al. Among authors: hartmann o. Crit Care. 2020 Apr 22;24(1):168. doi: 10.1186/s13054-020-02888-5. Crit Care. 2020. PMID: 32321571 Free PMC article.
421 results